A federal appeals court ruling against the Food and Drug Administration would have restricted access by mail to mifepristone.
A divided Supreme Court on Thursday indefinitely extended a freeze on strict new restrictions for dispensing the widely used abortion pill mifepristone while an underlying legal fight over the drug plays out.Why it matters: The widely expected order provides legal certainty for pharmacies, telehealth companies and clinicians caught up in the latest battle…
The Supreme Court ordered that patients could receive the abortion pill mifepristone through the mail and without an in-person appointment with a clinician after a ruling by the New Orleans-based 5th U.S. Circuit Court of Appeals on May 1 had imperiled widespread access to the pill.
The Supreme Court on Thursday allowed women to continue accessing the abortion pill Mifepristone through telehealth visits, blocking a lower court ruling that would have required in-person visits while litigation continues.CNN reported that the conservative court maintained its stay of a May 1 Fifth Circuit decision that "abruptly required women to obtain…
The Supreme Court has maintained mail access to the abortion pill mifepristone, setting aside for now a lower court order that blocked abortion providers from prescribing the widely used drug through telehealth and shipping it to patients.
The US Supreme Court let a widely used abortion pill continue to be dispensed by mail, putting on hold a federal appeals court decision that had briefly required patients to make an in-person visit to a provider. Kailey Leinz and Joe Mathieu report on "Balance of Power: Evening Edition." (Source: Bloomberg)
The high court’s decision allows providers to continue sending common abortion drug mifepristone to patients by mail.
The Supreme Court kept broader access to abortion pill mifepristone in place, allowing telehealth prescribing and mail delivery to continue.
The Supreme Court on Thursday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.
The Supreme Court restored access on Thursday to mail-order abortion pills nationwide, lifting an appeals court’s block on a 2023 FDA rule which had removed the in-person requirement for mifepristone. In an unsigned order, the high court ruled 7-2 in favor of issuing a stay, which indefinitely pauses a May 1 ruling by the U.S.…
